NC
Nicholas Company’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-169,745
| Closed | -$4.86M | – | 220 |
|
|
2024
Q2 | $4.86M | Buy |
169,745
+15,415
| +10% | +$441K | 0.08% | 192 |
|
|
2024
Q1 | $4.51M | Hold |
154,330
| – | – | 0.07% | 198 |
|
|
2023
Q4 | $5.21M | Hold |
154,330
| – | – | 0.09% | 192 |
|
|
2023
Q3 | $4.73M | Hold |
154,330
| – | – | 0.09% | 191 |
|
|
2023
Q2 | $6.18M | Sell |
154,330
-70
| -0% | -$2.81K | 0.12% | 171 |
|
|
2023
Q1 | $6.3M | Buy |
154,400
+11,690
| +8% | +$477K | 0.13% | 171 |
|
|
2022
Q4 | $5.51M | Hold |
142,710
| – | – | 0.12% | 178 |
|
|
2022
Q3 | $7.59M | Hold |
142,710
| – | – | 0.17% | 133 |
|
|
2022
Q2 | $8.32M | Buy |
142,710
+205
| +0.1% | +$12K | 0.18% | 130 |
|
|
2022
Q1 | $10.9M | Hold |
142,505
| – | – | 0.19% | 121 |
|
|
2021
Q4 | $8.58M | Buy |
142,505
+17,155
| +14% | +$1.03M | 0.14% | 165 |
|
|
2021
Q3 | $7.02M | Buy |
125,350
+10,015
| +9% | +$561K | 0.12% | 183 |
|
|
2021
Q2 | $7M | Buy |
115,335
+8,895
| +8% | +$540K | 0.12% | 190 |
|
|
2021
Q1 | $7.46M | Sell |
106,440
-50
| -0% | -$3.5K | 0.14% | 177 |
|
|
2020
Q4 | $6.37M | Buy |
+106,490
| New | +$6.37M | 0.12% | 188 |
|